# A Treatment Protocol for Patients With Gastrointestinal Stromal Tumor (GIST) Who May Derive Benefit From Treatment With SU011248

> **NCT00094029** · — · APPROVED_FOR_MARKETING · sponsor: **Pfizer**

## Conditions studied

- Gastrointestinal Neoplasm

## Interventions

- **DRUG:** Sutent

## Key facts

- **NCT ID:** NCT00094029
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** EXPANDED_ACCESS
- **Status:** APPROVED_FOR_MARKETING
- **Start date:** 2004-09
- **Primary completion:** 2011-10
- **Final completion:** 2011-10
- **Target enrollment:** — (—)
- **Last updated:** 2012-03-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00094029

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00094029, "A Treatment Protocol for Patients With Gastrointestinal Stromal Tumor (GIST) Who May Derive Benefit From Treatment With SU011248". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00094029. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*